Login / Signup
Hypermetabolism appears to be an adverse prognostic biomarker in amyotrophic lateral sclerosis: a potential for therapeutic intervention?
Steve Vucic
Published in:
European journal of neurology (2017)
Keyphrases
</>
randomized controlled trial
human health
risk assessment
climate change